Skip to content
stockresearch.app
CVS/History

CVS Health (CVS) valuation history

Above its usual range

As of

CVS's EV/EBITDA of 12.9x is higher than 78% of its available weekly readings from the last five years.

EV/EBITDA weekly history5.3×10.1×15×19.8×Shading: 5-year middle halfMedian 10.1×12.9×202120232025
Share EV/EBITDA history
Preview embed

Chart by stockresearch.app. Reuse with credit under CC BY 4.0.

EV/EBITDA at year-end

Last weekly reading of each completed year. Rank runs from lowest (0%) to highest (100%) within the five years available on that date.

CVS year-end valuation history
Reading dateEV/EBITDA5-year rank
16.0×99%
7.7×26%
8.0×15%
14.4×88%
10.1×70%
7.4×14%
11.3×65%
10.7×71%
8.2×11%
6.6×1%

Loading related research…

About this history

What is CVS's current EV/EBITDA?
CVS's EV/EBITDA of 12.9x is higher than 78% of its available weekly readings from the last five years.
What is CVS's five-year median EV/EBITDA?
The median, or middle weekly reading, is 10.1× over the last five years. Available history contains 859 weekly observations from May 10, 2010 to Oct 19, 2026.
Does a low historical rank mean a stock is a buy?
No. The rank describes a stock’s own history. Changes in growth, financial risk and the business can change the multiple investors pay. P/E uses earnings and P/S uses revenue from the previous twelve months.

Source: SEC company filings and weekly market prices. Multiples use the previous twelve months of financial results. Updated .

Read the valuation methodology